DBTX Stock: Decibel Therapeutics, Inc. Stock Price, Analysis & Insights

Get live DBTX stock price $4.91, comprehensive Decibel Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time DBTX stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

4.91

0.81%Today

DBTX • Decibel Therapeutics, Inc. • NASDAQ Global Select • Healthcare

Market Cap

123.37M

Volume

1.06M

52W High

5.40

52W Low

1.61

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Decibel Therapeutics, Inc. (DBTX) is a clinical-stage biotechnology firm dedicated to pioneering innovative therapies for a range of hearing and balance impairments. Their research and development efforts are concentrated across three primary therape...

Contact Information

Website: https://www.decibeltx.com
Address: 1325 Boylston Street
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -0.40) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Decibel Therapeutics, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Decibel Therapeutics, Inc.
⚠Investors should consider how Decibel Therapeutics, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

123.37M

P/E Ratio (TTM)

-1.93

Beta

-0.40

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare DBTX with peer companies:

aTyr Pharma, Inc. (ATYR)

Price: $0.46
Market cap: 45.06M

Graybug Vision, Inc. (GRAY)

Price: $5.50
Market cap: 120.98M

Jounce Therapeutics, Inc. (JNCE)

Price: $1.88
Market cap: 98.95M

Kinnate Biopharma Inc. (KNTE)

Price: $2.65
Market cap: 124.99M

NGM Biopharmaceuticals, Inc. (NGM)

Price: $1.54
Market cap: 128.53M

Pardes Biosciences, Inc. (PRDS)

Price: $2.18
Market cap: 135.19M

Paratek Pharmaceuticals, Inc. (PRTK)

Price: $2.23
Market cap: 127.83M

Selecta Biosciences, Inc. (SELB)

Price: $0.88
Market cap: 135.20M

Sesen Bio, Inc. (SESN)

Price: $0.63
Market cap: 127.96M

Tourmaline Bio, Inc. (TRML)

Price: $47.98
Market cap: 1.23B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.